SCHEMBL11903471

SCHEMBL11903471

FC(F)(F)Oc1ccc2nc(-c3ccco3)[nH]c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY6 Q15077 2/20 0.67
ALOX5 P09917 1/20 0.60
EPHX2 P34913 1/20 0.60
RUNX1 Q01196 7/20 0.59
CBFB Q13951 3/20 0.59
TRPV1 Q8NER1 1/20 0.56
CHEK1 O14757 1/20 0.54
LIMK1 P53667 1/20 0.54
CDK5 Q00535 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54
ALDH1A1 P00352 4/20 0.51
RAB9A P51151 3/20 0.51
KDM4E B2RXH2 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MAPT P10636 3/20 0.50
POLB P06746 2/20 0.50
KMT2A Q03164 2/20 0.50
HSD17B10 Q99714 2/20 0.50
PKM P14618 1/20 0.50
NPC1 O15118 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11903475 0.90 P2RY6 (0.56) P2RY6ALOX5EPHX2RUNX1CBFB
SCHEMBL11903481 0.79 TRPV1 (0.72) RUNX1CBFBTRPV1ALDH1A1RAB9A
SCHEMBL8603371 0.78 ALOX5 (0.73) P2RY6ALOX5EPHX2CHEK1LIMK1
SCHEMBL12082439 0.75 ALOX5 (0.69) ALOX5EPHX2CBFBCHEK1LIMK1
SCHEMBL10758216 0.75 ALOX5 (1.00) ALOX5EPHX2CHEK1LIMK1CDK5
SCHEMBL11903492 0.75 NPC1 (0.66) RUNX1CBFBTRPV1ALDH1A1RAB9A
SCHEMBL11903468 0.75 TRPV1 (0.74) RUNX1CBFBTRPV1ALDH1A1RAB9A
SCHEMBL11903462 0.74 ALDH1A1 (0.60) P2RY6RUNX1CBFBTRPV1ALDH1A1
SCHEMBL11903652 0.74 TRPV1 (0.77) RUNX1CBFBTRPV1ALDH1A1RAB9A
SCHEMBL11903498 0.74 TRPV1 (0.77) RUNX1CBFBTRPV1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293780-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making U.S. DEPARTMENT OF ENERGY (US) 2012-10-23 US claimed
US-8293780-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making U.S. DEPARTMENT OF ENERGY (US) 2012-10-23 US disclosed
US-8293780-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making U.S. DEPARTMENT OF ENERGY (US) 2012-10-23 US disclosed
US-8242284-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 2012-08-14 US disclosed
US-8242284-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 2012-08-14 US disclosed